The effect of ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131

Thyroid

Volumn 22, Issue 3, 2012, Pages 318-324

  Dardano, Angela ^a   Ballardin, Michela ^a   Caraccio, Nadia ^a   Boni, Giuseppe ^a   Traino, Claudio ^b   Mariani, Giuliano ^a   Ferdeghini, Marco ^c   Barale, Roberto ^a   Monzani, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLASTOGEN; GINKGO BILOBA EXTRACT; IODINE 131; LIOTHYRONINE; PLACEBO; THYROGLOBULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FREE THYROXINE INDEX; GENOTOXICITY; HUMAN; LYMPHOCYTE; MALE; MICRONUCLEUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THYROID FUNCTION TEST;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; GINKGO BILOBA; HERB-DRUG INTERACTIONS; HUMANS; IODINE RADIOISOTOPES; LYMPHOCYTES; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MIDDLE AGED; MUTAGENS; PLANT EXTRACTS; RADIATION INJURIES; RADIOPHARMACEUTICALS; THYROID FUNCTION TESTS; THYROID NEOPLASMS;

EID: 84857867817     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.0398     Document Type: Article

References (46)

1. Popova L, Hadjidekova V, Hadjieva T, Agova S, Vasilev I 2005 Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma. Hell J Nucl Med 8:54-57.
2. Ballardin M, Gemignani F, Bodei L, Mariani G, Ferdeghini M, Rossi AM, Migliore L, Barale R 2002 Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Mutat Res 514:77-85.
3. Frigo A, Dardano A, Danese E, Davì MV, Moghetti P, Colato C, Francia G, Bernardi F, Traino C, Monzani F, Ferdeghini M 2009 Chromosome translocation frequency after radioiodine thyroid remnant ablation: A comparison between recombinant human thyrotropin stimulation and prolonged levothyroxine withdrawal. J Clin Endocrinol Metab 94:3472-3476.
4. Hernández-Jardines A, Molina B, del Castillo V, Papadakis M, Rivera T, Azorín J, Herrera LA, Yokoyama E, Frías S 2010 Detection of short-term chromosomal damage due to therapeutic 131I exposure in patients with thyroid cancer. Rev Invest Clín 62:31-38.
5. de Vathaire F 2008 The carcinogenic effects of radioiodine therapy for thyroid carcinoma. Nat Clin Pract Endocrinol Metab 4:180-181.
6. Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB 2010 Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008.World J Surg 34:1192-1202.
7. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD 2008 The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 93:504-515.
8. Mateuca R, Lombaert N, Aka PV, Decordier I, Kirsch-Volders M 2006 Chromosomal changes: Induction, detection methods and applicability in human biomonitoring. Biochimie 88:1515-1531.
9. Iarmarcovai G, Ceppi M, Botta A, Orsière T, Bonassi S 2008 Micronuclei frequency in peripheral blood lymphocytes of cancer patients: A meta-analysis. Mutat Res 659:274-283.
10. Dardano A, Ballardin M, Ferdeghini M, Lazzeri E, Traino C, Caraccio N, Mariani G, Barale R, Monzani F 2007 Anticlastogenic effect of Ginkgo biloba extract in Graves' disease patients receiving radioiodine therapy. J Clin Endocrinol Metab 92:4286-4289.
11. Fenech M, Morley AA 1985 Measurement of micronuclei in lymphocytes. Mutat Res 147:29-36.
12. Emerit I 1999 Clastogenic factors: Detection and assay. In: Packer L, Glazer AN (eds) Methods in Enzymology. Academic Press, New York, pp 555-564.
13. Ambrosetti MC, Colato C, Dardano A, Monzani F, Ferdeghini M 2009 Radioiodine ablation: When and how. Q J Nucl Med Mol Imaging 53:473-481.
14. Van Nostrand D 2009 The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer. Thyroid 19:1381-1391.
15. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
16. Joseph LJ, Bhartiya US, Raut YS, Kand P, Hawaldar RW, Nair N 2009 Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis. Mutat Res 675:35-40.
17. Hyer SL, Newbold K, Hamer CL 2010 Early and late toxicity of radioiodine: Detection and management. Endocr Pract 14:1-20.
18. Bondeson L, Bengtsson A, Bondeson AG, Dahlenfors R, Grimelius L, Wedell B, Mark J 1989 Chromosome studies in thyroid neoplasia. Cancer 64:680-685.
19. Baugnet-Mahieu L, Lemaire M, Léonard ED, Léonard A, Gerber GB 1994 Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 140:429-431.
20. Gundy S, Katz N, Füzy M, Esik O 1996 Cytogenetic study of radiation burden in thyroid disease patients treated with external irradiation or radioiodine. Mutat Res 360:107-113.
21. Loft S, Poulsen HE 1996 Cancer risk and oxidative DNA damage in man. J Mol Med 74:297-312.
22. Emerit I 1982 Chromosome breakage factors: Origin and possible significance. Prog Mutat Res 4:61-74.
23. Emerit I 1994 Reactive oxygen species, chromosome mutation, and cancer: Possible role of clastogenic factors in carcinogenesis. Free Radic Biol Med 16:99-10.
24. Fenech M, Bonassi S 2011 The effect of age, gender, diet and lifestyle on DNA damage measured using micronucleus frequency in human peripheral blood lymphocytes. Mutagenesis 26:43-49.
25. Rong Y, Geng Z, Lau BH 1996 Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells. Free Radic Biol Med 20:121-127.
26. Yuan F, Yu R, Yin Y, Shen J, Dong Q, Zhong L, Song L 2010 Structure characterization and antioxidant activity of a novel polysaccharide isolated from Ginkgo biloba. Int J Biol Macromol 46:436-439.
27. Tunali-Akbay T, Sener G, Salvarli H, Sehirli O, Yarat A 2007 Protective effects of Ginkgo biloba extract against mercury( II)-induced cardiovascular oxidative damage in rats. Phytother Res 21:26-31.
28. Kanowski S, Hoerr R 2003 Ginkgo biloba extract EGb 761 in dementia: Intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 36:297-303.
29. Maitra I, Marcocci L, Droy-Lefaix MT, Packer L 1995 Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol 49:1649-1655.
30. Smith JV, Luo Y 2004 Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol 64: 465-472.
31. Smith JV, Luo Y 2003 Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis 5:287-300.
32. Sarikcioglu SB, Oner G, Tercan E 2004 Antioxidant effect of EGb 761 on hydrogen peroxide-induced lipoperoxidation of G-6-PD deficient erythrocytes. Phytother Res 18:837-840.
33. Pierre S, Jamme I, Droy-Lefaix MT, Nouvelot A, Maixent JM 1999 Ginkgo biloba extract (EGb 761) protects Na, K-ATPase activity during cerebral ischemia in mice. Neuroreport 10:47-51.
34. Pietri S, Séguin JR, d'Arbigny P, Drieu K, Culcasi M 1997 Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther 11: 121-131.
35. Köse K, Dogan P 1995 Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidants. J Int Med Res 23:9-18.
36. Koltermann A, Hartkorn A, Koch E, Fürst R, Vollmar AM, Zahler S 2007 Ginkgo biloba extract EGb 761 increases endothelial nitric oxide production in vitro and in vivo. Cell Mol Life Sci 64:1715-1722.
37. Dong XX, Hui ZJ, Xiang WX, Rong ZF, Jian S, Zhu CJ 2007 Ginkgo biloba extract reduces endothelial progenitor-cell senescence through augmentation of telomerase activity. J Cardiovasc Pharmacol 49:111-115.
38. Cheng SM, Yang SP, Ho LJ, Tsao TP, Juan TY, Chang DM, Chang SY, Lai JH 2003 Down-regulation of c-jun N-terminal kinase-activator protein-1 signaling pathway by Ginkgo biloba extract in human peripheral blood T cells. Biochem Pharmacol 66:679-689.
39. Zhang Y, Chen AY, Li M, Chen C, Yao Q 2008 Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J Surg Res 148: 17-23.
40. Emerit I, Arutyunyan R, Oganesian N, Levy A, Cernjavsky L, Sarkisian T, Pogossian A, Asrian K 1995 Radiation-induced clastogenic factors: Anticlastogenic effect of Ginkgo biloba extract. Free Radic Biol Med 18:985-991.
41. Emerit I, Oganesian N, Sarkisian T, Arutyunyan R, Pogosian A, Asrian K, Levy A, Cernjavski L 1995 Clastogenic factors in the plasma of Chernobyl accident recovery workers: Anticlastogenic effect of Ginkgo biloba extract. Radiat Res 144:198-205.
42. Shi C, Zhao L, Zhu B, Li Q, Yew DT, Yao Z, Xu J 2009 Dosage effects of EGb761 on hydrogen peroxide-induced cell death in SH-SY5Y cells. Chem Biol Interact 180:389-397.
43. Kang JW, Kim JH, Song K, Kim SH, Yoon JH, Kim KS 2010 Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells Phytother Res 24:S77-S82.
44. Pacini F, Molinaro E, Castagna MG, Lippi F, Ceccarelli C, Agate L, Elisei R, Pinchera A 2002 Ablation of thyroid residues with 30 mCi (131) I: A comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 87:4063-4068.
45. Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P 2007 Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer 109:1972-1197.
46. Bonassi S, Fenech M, Lando C, Lin YP, Ceppi M, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Jia C, Di Giorgio M, Ferguson LR, Fucic A, Lima OG, Hrelia P, Krishnaja AP, Lee TK, Migliore L, Mikhalevich L, Mirkova E, Mosesso P, Müller WU, Odagiri Y, Scarffi MR, Szabova E, Vorobtsova I, Vral A, Zijno A 2001 Human MicroNucleus project: International database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen 37:31-45.